Neuralgia News and Research

RSS
Neuralgia is pain in one or more nerves that occurs without stimulation of pain receptor (nociceptor) cells. Neuralgia pain is produced by a change in neurological structure or function rather than by the excitation of pain receptors that causes nociceptive pain.
Sales of Cobroxin exceeds XenaCare Holdings' projections for first 45 days of 2010

Sales of Cobroxin exceeds XenaCare Holdings' projections for first 45 days of 2010

San Antonio Methodist Hospital upgrades to Leksell Gamma Knife Perfexion system

San Antonio Methodist Hospital upgrades to Leksell Gamma Knife Perfexion system

Peripheral nerve stimulation promising for treatment of post-herpetic neuralgia

Peripheral nerve stimulation promising for treatment of post-herpetic neuralgia

CPS supports NACI recommendations for new shingles vaccine

CPS supports NACI recommendations for new shingles vaccine

Sales of Nutra Pharma's Cobroxin totaled $583,955 for fourth-quarter ending December 31, 2009

Sales of Nutra Pharma's Cobroxin totaled $583,955 for fourth-quarter ending December 31, 2009

Depomed expands patent portfolio around extended release gabapentin formulation technology

Depomed expands patent portfolio around extended release gabapentin formulation technology

EpiCept's NP-1 for treatment of PHN receives FDA orphan drug designation

EpiCept's NP-1 for treatment of PHN receives FDA orphan drug designation

Endo Pharmaceuticals' partners receive Paragraph IV Certification Notice regarding LIDODERM

Endo Pharmaceuticals' partners receive Paragraph IV Certification Notice regarding LIDODERM

Watson Laboratories files ANDA for Lidoderm

Watson Laboratories files ANDA for Lidoderm

Pfizer commences recruitment for Phase I clinical trial of SA3Ag vaccine

Pfizer commences recruitment for Phase I clinical trial of SA3Ag vaccine

VELCADE sNDA receives FDA approval

VELCADE sNDA receives FDA approval

UPMC reports 10,000th patient treated using Elekta's Leksell Gamma Knife system

UPMC reports 10,000th patient treated using Elekta's Leksell Gamma Knife system

VERTICAL Phase II trial results for NHL released

VERTICAL Phase II trial results for NHL released

Clinical trial results of VELCADE based combinations for MM to be presented at the ASH meeting

Clinical trial results of VELCADE based combinations for MM to be presented at the ASH meeting

VELCADE based regimens are cost-effective for payers and patients, finds study

VELCADE based regimens are cost-effective for payers and patients, finds study

Endo Pharmaceuticals receives FDA complete response letter for AVEED NDA

Endo Pharmaceuticals receives FDA complete response letter for AVEED NDA

XenaCare Holdings becomes national sponsor of Arthritis Foundation

XenaCare Holdings becomes national sponsor of Arthritis Foundation

Epiphany Biosciences announces results from its valomaciclovir Phase 2b trial for shingles

Epiphany Biosciences announces results from its valomaciclovir Phase 2b trial for shingles

FDA approves Qutenza, a pain relief product for patients who suffer from PHN

FDA approves Qutenza, a pain relief product for patients who suffer from PHN

FDA approves NeurogesX's Qutenza patch for postherpetic neuralgia treatment

FDA approves NeurogesX's Qutenza patch for postherpetic neuralgia treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.